Press Releases

NEW POST

8 November 2021 in Investor Center

Imagin Medical Announces Appointment of Kayvon Namvar to Board of Directors and Kevin Slawin, M.D. as Board Chairman

Vancouver, B.C. and Boston, MA, November 8, 2021 – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) “Imagin” or the “Company”), a surgical imaging company visualizing cancer in vital new ways…
Read More
30 August 2021 in Investor Center

Rapha Capital Leads New $3 Million Convertible Note Financing in Imagin Medical, Inc.

Rapha Capital BioVentures Fund I, LP (RCBVFI) managed by Rapha Capital leads the financing. Kevin Slawin, M.D., a leading urooncologist and manager of RCBVFI, joins the board. Imagin Medical's i/Blue™…
Read More
26 August 2021 in Investor Center

IMAGIN MEDICAL Secures New $3 Million Convertible Note Financing

Rapha Capital BioVentures Fund I, LP (RCBVFI), Leads New Convertible Note Financing Kevin Slawin, MD, a Leading UroOncologist and Manager of RCBVFI Joins the Board Imagin Medical’s i/Blue™ Imaging System is…
Read More
18 August 2021 in Investor Center

InvestorNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) to Demonstrate Advanced Capabilities of i/Blue Imaging System(TM) at AUA Annual Meeting

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company focused on establishing a new standard of care in visualizing cancer during minimally invasive procedures, today announced that the final…
Read More
17 August 2021 in Investor Center

Imagin Medical Reports Company on Schedule for American Urology Association Demonstration

Vancouver, B.C. and Boston, MA, August 17, 2021 – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported that the final…
Read More
6 August 2021 in Investor Center

InvestorNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Poised to Establish New Standard in Bladder Cancer Visualization

Imagin Medical (CSE: IME) (OTCQB: IMEXF) has developed the i/Blue Imaging System(TM), an innovative technology designed to significantly improve the way surgeons visualize cancerous cells for more accurate bladder resection.…
Read More
19 May 2021 in Investor Center

Imagin Medical Reports Company on Schedule for Product Demonstration

Vancouver, B.C. and Boston, MA, May 19, 2021 – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported continued progress towards…
Read More
16 March 2021 in Investor Center

Imain Medical Reports Manufacturing Progress

Vancouver, B.C. and Boston, MA, March 16, 2021 – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported continued progress towards…
Read More
18 February 2021 in Investor Center

Imagin Medical Closes Second Tranche of Convertible Note Offering

Vancouver, B.C. and Boston, MA, Feb. 18, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD3) (“Imagin” or the “Company”)…
Read More
13 January 2021 in Investor Center

Imagin Medical Builds Momentum for 2021

VANCOUVER, British Columbia, and BOSTON, Jan. 13, 2021 -- via InvestorWire – Imagin Medical (CSE: IME) (OTC: IMEXF) (FRA: DPD2) (the “Company”) announces that critical milestones met in the second…
Read More
4 January 2021 in Investor Center

Imagin Medical Engages Torrey Hills Capital

VANCOUVER, British Columbia, and BOSTON, Jan. 20, 2021 – via InvestorWire – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (FSE: DPD2) ("Imagin" or the "Company") is pleased to announce that…
Read More
10 November 2020 in Investor Center

Imagin Medical Closes First Tranche of Convertible Notes Offering

Vancouver, B.C. and Boston, MA, November 10, 2020 – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that, further to…
Read More
26 October 2020 in Investor Center

Imagin Medical Announces Agenda for KOL Virtual Investor Event on October 29, 2020

Vancouver, B.C. and Boston, MA, October 26, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced the agenda for its…
Read More
22 October 2020 in Investor Center

Imagin Medical Announces Proposed Offering of $3 Million of Convertible Notes and Share Consolidation

Vancouver, B.C. and Boston, MA, October 22, 2020 – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced its intention to:…
Read More
7 October 2020 in Investor Center

Imagin Medical Selects Lighthouse Imaging as i/Blue Imaging System Contract Manufacturer

Vancouver, B.C. and Boston, MA, October 7, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that it has selected…
Read More
29 September 2020 in Investor Center

Imagin Medical to Host KOL Webcast Event on October 29, 2020

Vancouver, B.C. and Boston, MA, September 29, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that it will host…
Read More
28 August 2020 in Investor Center

Imagin Medical Reports Fiscal 2020 Third Quarter Results

Vancouver, B.C. and Boston, MA, August 28, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for the…
Read More
12 July 2020 in Investor Center

Imagin Medical To Begin Testing of i/Blue Imaging System on Anatomical Bladder Models

- New Video, Podcast Episode Available on Imagin Medical’s Website - Vancouver, B.C. and Boston, MA, July 15, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol:…
Read More
28 May 2020 in Investor Center

Imagin Medical Imagin Medical Reports Fiscal 2020 Second Quarter Results

Vancouver, B.C. and Boston, MA, May 28, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for the…
Read More
21 May 2020 in Investor Center

Imagin Medical To Report Second Fiscal Quarter 2020 Financial Results on May 28, 2020 – Conference Call

Vancouver, B.C. and Boston, MA, May 21, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) announced today that its financial results…
Read More
21 May 2020 in Investor Center

Imagin Medical Announces Successful Delivery of Functional i/Blue Imaging System

Vancouver, B.C. and Boston, MA, May 21, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that its contract design…
Read More
14 May 2020 in Investor Center

Imagin Medical Reports Response to Covid-19

Vancouver, B.C. and Boston, MA, May 14, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today provided an update on the…
Read More
12 May 2020 in Investor Center

Imagin Medical Supports Cancer Awareness Month

Vancouver, B.C. and Boston, MA, May 12, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) announces its support of Bladder Cancer…
Read More
9 April 2020 in Investor Center

Imagin Medical Receives Approval to Reprice and Extend Term of Warrants

Vancouver, B.C. and Boston, MA, April 9, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) announces that it has received approval…
Read More
10 March 2020 in Investor Center

Imagin Medical Reports Physician Feedback on i/Blue Imaging System for Bladder Cancer Visualization

Vancouver, B.C. and Boston, MA, March 10, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported ongoing market research feedback…
Read More
27 February 2020 in Investor Center

Imagin Medical Reports Fiscal 2020 First Quarter Results

Vancouver, B.C. and Boston, MA, February 27, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for the…
Read More
20 February 2020 in Investor Center

Imagin Medical to Report First Fiscal Quarter 2020 Financial Results on February 27, 2019 – Conference Call to Follow

Vancouver, B.C. and Boston, MA, February 20, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) announced today that its financial results…
Read More
10 February 2020 in Investor Center

Imagin Medical to Present at NobleCon16

Vancouver, B.C. and Boston, MA, February 10, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) announced today that its President and…
Read More
23 January 2020 in Investor Center

Imagin Medical Finishes 2019 Strong and Provides Insight into 2020 and Beyond

Vancouver, B.C. and Boston, MA, January 23, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today provided a corporate update to…
Read More
21 January 2020 in Investor Center

Imagin Medical Closes Oversubscribed Private Placement

Vancouver, B.C. and Boston, MA, January 21, 2020 – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that, further to…
Read More
10 January 2020 in Investor Center

Imagin Medical Announces Stock Option Grant

Vancouver, B.C. and Boston, MA, January 10, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced today that, pursuant to…
Read More
8 January 2020 in Investor Center

Imagin Medical Reports Successful Completion of Design Verification and Announces Private Placement

Vancouver, B.C. and Boston, MA, January 8, 2020 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that it completed design…
Read More
24 December 2019 in Investor Center

Imagin Medical Reports Fiscal Year End 2019 Results

Vancouver, B.C. and Boston, MA, December 24, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for its…
Read More
18 December 2019 in Investor Center

Imagin Medical Announces Results of Annual Meeting of Shareholders

Vancouver, B.C. and Boston, MA, December 18, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) is pleased to announce the results…
Read More
3 December 2019 in Investor Center

Imagin Medical to Present at the First Annual BIOTuesdays Pre-JPM Virtual Conference

Vancouver, B.C. and Boston, MA, December 3, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that management will present…
Read More
17 October 2019 in Investor Center

Imagin Medical Announces Social Media Campaign Launch

Vancouver, B.C. and Boston, MA, – October 17, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) is pleased to announce the…
Read More
26 September 2019 in Investor Center

Imagin Medical Announces Meeting Regarding i/Blues’s Regulatory Pathway

Vancouver, B.C. and Boston, MA, September 26, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced it recently met with…
Read More
27 August 2019 in Investor Center

Imagin Medical Reports Fiscal 2019 Third Quarter Results

Vancouver, B.C. and Boston, MA, August 27, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for the…
Read More
15 July 2019 in Investor Center

Imagin Medical Progress Update

Vancouver, B.C. and Boston, MA, July 15, 2019 – Imagin Medical (CSE: IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reportedcontinued progress toward verification of its…
Read More
24 June 2019 in Investor Center

Imagin Medical Announces Stock Option Grant

Vancouver, B.C. and Boston, MA, June 24, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced that, under its stock option plan, it…
Read More
11 June 2019 in Investor Center

Imagin Medical Reports Fiscal 2019 Second Quarter Financial Results

Vancouver, B.C. and Boston, MA, June 11, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for the…
Read More
6 June 2019 in Investor Center

Imagin Medical to Report Fiscal 2019 Second Quarter Results on June 11, 2019 – Conference Call to Follow

Vancouver, B.C. and Boston, MA, June 3, 2019 – Imagin Medical (CSE: IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”), an emerging leaderin the development and commercialization…
Read More
17 April 2019 in Investor Center

Imagin Medical Welcomes World-Renowned Bladder Cancer Expert Dr. Ashish Kamat to Its Scientific Board of Advisors

Vancouver, B.C. and Boston, MA, April 17, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that Dr. Ashish M.…
Read More
27 February 2019 in Investor Center

Imagin Medical Completes Assembly of i/Blue Imaging Functional Unit

Vancouver, B.C. and Boston, MA, February 27, 2019 – Imagin Medical (CSE: IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reportedfinancial results for the three months…
Read More
19 February 2019 in Investor Center

Imagin Medical to Report Fiscal Q1 2019 Results on February 27, 2019 – Conference Call to Follow

Vancouver, B.C. and Boston, MA, February 19, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”), an emerging leader in the development…
Read More
23 January 2019 in Investor Center

Imagin Medical to Present at Noble Capital Markets 15th Annual Investor Conference

Vancouver, B.C. and Boston, MA, January 23, 2018 – Imagin Medical (CSE: IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”), an emerging leader in the development and…
Read More
9 January 2019 in Investor Center

Imagin Medical Posts New Presentation on Its Website

Vancouver, B.C. and Boston, MA, January 9, 2018 – Imagin Medical (CSE: IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that, ahead of its planned…
Read More
20 December 2018 in Investor Center

Imagin Medical Reports Fiscal Year End 2018 Results

Vancouver, B.C. and Boston, MA, December 20, 2018 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for the…
Read More
18 December 2018 in Investor Center

Imagin Medical Announces Results of Annual Meeting of Shareholders

Vancouver, B.C. and Boston, MA, December 18, 2018 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) is pleased to announce the results…
Read More
28 November 2018 in Investor Center

Imagin Medical Comments on Recent Promotional Activity Pursuant to OTC Markets Request

Vancouver, B.C. and Boston, MA, November 28, 2018 – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) wishes to make the following…
Read More
31 October 2018 in Investor Center

Imagin Medical Receives Approximately $1 from Exercise of Warrants

Vancouver, B.C. and Boston, MA, October 31, 2018 – Imagin Medical (CSE: IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) announced today that it has received proceeds…
Read More
2 October 2018 in Investor Center

Imagin Medical Announces Changes to its Board of Directors

Vancouver, B.C. and Boston, MA, October 2, 2018 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) announced that Steven Chan has resigned…
Read More
14 August 2018 in Investor Center

Imagin Medical Reports Fiscal 2018 Third Quarter Results

Vancouver, B.C. and Boston, MA, August 14, 2018 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for the…
Read More
25 July 2018 in Investor Center

Imagin Medical Announces Stock Options Granted

Vancouver, B.C. and Boston, MA, July 25, 2018 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today that, pursuant to the Company’s Stock…
Read More
17 July 2018 in Investor Center

Imagin Medical Reports Research Study Progress

Vancouver, B.C. and Boston, MA, July, 17, 2018 – Imagin Medical (CSE: IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) announced todayfavorable results in the 10-subject investigator-sponsored…
Read More
27 June 2018 in Investor Center

Imagin Medical Announces Uplisting to OTCQB

Vancouver, BC and Boston, MA, June 27, 2018 – Imagin Medical (CSE: IME) (OTCPINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) is pleased to announce that its…
Read More
22 June 2018 in Investor Center

Imagin Medical Provides Further Details on Kilmer Lucas Engagement

Vancouver, BC and Boston, MA, June 22, 2018 – Imagin Medical (CSE: IME) (OTCPINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) is pleased to provide, in addition…
Read More
21 June 2018 in Investor Center

Imagin Engages Kilmer Lucas for Cross-border Investor Relations

Vancouver, BC and Boston, MA, June 20, 2018 – Imagin Medical (CSE: IME) (OTCPINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that it has engaged…
Read More
26 April 2018 in Investor Center

Imagin Gains Momentum; Positive Progress in Research Study

Vancouver, B.C. and Boston, MA, April 26, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) is providing the following update on the…
Read More
19 April 2018 in Investor Center

IME Closes Oversubscribed Private Placement

Vancouver, B.C. and Boston, MA, April 19, 2018 – Imagin Medical, Inc. (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announces that, further to its press releases…
Read More
12 April 2018 in Investor Center

Imagin Medical Closing Private Placement

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive…
Read More
3 April 2018 in Investor Center

Imagin Medical Announces Private Placement

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive…
Read More
8 March 2018 in Investor Center

Imagin Medical Closes Private Placement

Vancouver, B.C. and Boston, MA, March 8, 2018 – Imagin Medical Inc. (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today the closing of a…
Read More
7 March 2018 in Investor Center

Imagin Medical Product Re-Design on Schedule

Vancouver, B.C. and Boston, MA, March 7, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”), announced today that the Company expects the…
Read More
1 March 2018 in Investor Center

Imagin Medical Announces Private Placement

Vancouver, B.C. and Boston, MA, March 1, 2018 – Imagin Medical Inc. (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today the offering of a…
Read More
26 February 2018 in Investor Center

Imagin Medical Appoints Director of Regulatory Affairs

Vancouver, B.C. and Boston, MA, February 26, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”), announced today the Company has hired Pam…
Read More
15 February 2018 in Investor Center

Imagin Medical Closes Private Placement

Vancouver, B.C. and Boston, MA, February 15, 2018 – Imagin Medical Inc. (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today the closing of a…
Read More
9 February 2018 in Investor Center

American Urological Association (AUA) Honors Imagin Medical Scientific Advisor

Vancouver, B.C. and Boston, MA, February 9, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”), announced today that the lead investigator on…
Read More
7 February 2018 in Investor Center

University of Rochester Initial Research Study Patients Completed

Vancouver, B.C. and Boston, MA, February 7, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”), as a follow-up to the announcement dated…
Read More
30 January 2018 in Investor Center

John Vacha Joins Imagin Medical Board of Directors

Vancouver, B.C. and Boston, MA, January 30, 2018– Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that John Vacha, the Company’s recently appointed…
Read More
30 January 2018 in Investor Center

Imagin Medical Announces Private Placement

Vancouver, B.C. and Boston, MA, January 30, 2018 – Imagin Medical Inc. (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today the offering of a…
Read More
22 January 2018 in Investor Center

Imagin Medical Research Study Begins

Vancouver, B.C. and Boston, MA, January 9, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today that pursuant to the Company’s…
Read More
17 January 2018 in Investor Center

Imagin Medical Stock Options Granted

Vancouver, B.C. and Boston, MA, January 17, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today that pursuant to the Company’s…
Read More
15 January 2018 in Investor Center

Imagin Medical Recruits Senior Healthcare CFO

Vancouver, B.C. and Boston, MA, January 15, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today that it hired John Vacha…
Read More
9 January 2018 in Investor Center

Imagin Medical Stock Option Granted

Vancouver, B.C. and Boston, MA, January 9, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today that pursuant to the Company’s…
Read More
9 January 2018 in Investor Center

Imagin Medical Builds Momentum for 2018

Vancouver, B.C. and Boston, MA, January 9, 2018 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced that critical milestones were met in…
Read More
14 December 2017 in Investor Center

Imagin Medical Stock Options Granted

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting cancers and visualizing the surgical field in…
Read More
8 December 2017 in Investor Center

Imagin Medical Investors Exercise Warrants Generating $1M

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting cancers and visualizing the surgical field in…
Read More
29 November 2017 in Investor Center

Imagin Medical Opens Enrollment for Research Study

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting cancers and visualizing the surgical field in…
Read More
28 November 2017 in Investor Center

Imagin Medical Stock Options Granted

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting cancers and visualizing the surgical field in…
Read More
9 November 2017 in Investor Center

Prototype Redesign

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting cancers and visualizing the surgical field in…
Read More
6 November 2017 in Investor Center

Enhanced Cystoscopy Improves Bladder Cancer Detection

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting cancers and visualizing the surgical field in…
Read More
27 October 2017 in Investor Center

Imagin Medical Scientific Advisor Attends Society of International Urology Meeting

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting cancers and visualizing the surgical field in…
Read More
26 October 2017 in Investor Center

Imagin Medical Announces Stock Options Granted

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting cancers and visualizing the surgical field in…
Read More
26 October 2017 in Investor Center

Imagin Medical Announces PP for Communications

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting cancers and visualizing the surgical field in…
Read More
19 October 2017 in Investor Center

Imagin Medical Announces Clinical Research Criteria

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care for urologists in detecting cancers and visualizing the surgical field in…
Read More
18 October 2017 in Investor Center

Imagin Medical Closed $1M Private Placement

 Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive…
Read More
13 October 2017 in Investor Center

Imagin Medical Closing 2nd and Final Tranche of $1M Private Placement

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive…
Read More
11 October 2017 in Investor Center

Urologists Invest in Imagin Medical Private Placement

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive…
Read More
5 October 2017 in Investor Center

Clinical Research Study Listed on Government Website

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive…
Read More
4 October 2017 in Investor Center

Imagin Medical Closing Tranche 1 and Increasing Private Placement Offering

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive…
Read More
27 September 2017 in Investor Center

Imagin Medical Receives 1st In-Human Research Study Approval

Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive…
Read More
26 September 2017 in Investor Center

Imagin Medical Announces Private Placement

Vancouver, B.C. and Boston, MA, September 26, 2017 – Imagin Medical, Inc. (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today the offering of a non-brokered…
Read More
28 June 2017 in Investor Center

2017 Mid Year Update

Vancouver, B.C. and Boston, MA, June 28, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) released today a mid-year report to keep investors…
Read More
10 April 2017 in Investor Center

New Release – Imagin Medical Grants Stock Options

Vancouver, B.C. and Boston, MA, April 10, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today that pursuant to the Company’s…
Read More
3 March 2017 in Investor Center

Imagin Medical Closes Private Placement of Convertible Notes

Vancouver, B.C. and Boston, MA, March 3, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that it has closed the private…
Read More
24 February 2017 in Investor Center

Imagin Medical Arranges Private Placement of Convertible Notes

Vancouver, B.C. and Boston, MA, February 24, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that it will issue on a…
Read More
22 February 2017 in Investor Center

Imagin Medical Signs $8M Term Sheet with New York Private Equity Firm Alumina Partners LLC

Vancouver, B.C. and Boston, MA, February 22, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that it has executed a non-binding…
Read More
9 February 2017 in Investor Center

Imagin Medical Technology Presented at Photonics West 2017

Vancouver, B.C. and Boston, MA, February 9, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that the i/Blue Imaging System technology…
Read More
2 February 2017 in Investor Center

Imagin Medical Final Product Design on Track

Vancouver, B.C. and Boston, MA, March 2, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that the Company and Optel, Inc.,…
Read More
10 January 2017 in Investor Center

Imagin Medical Poised for 2017 Success

Vancouver, B.C. and Boston, MA, January 10, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that, during 2016, the Company laid…
Read More
9 December 2016 in Investor Center

Imagin Medical Closes Tranche 2 of Private Placement

Vancouver, B.C. and Boston, MA, December 9 , 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that, further to its press…
Read More
8 December 2016 in Investor Center

Imagin Medical Chooses Optel, Inc. to Design i/Blue Prototype for Commercialization

Vancouver, B.C. and Boston, MA, December 8, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that it is partnering with Optel,…
Read More
1 December 2016 in Investor Center

Imagin Medical Completes Alpha B Prototype

Vancouver, B.C. and Boston, MA, December 1, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that it has completed development of…
Read More
10 November 2016 in Investor Center

Dr. Roger Buckley Joins Imagin Medical’s Scientific Board of Advisors

Vancouver, B.C. and Boston, MA, November10, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that Dr. Roger J. Buckley, has joined…
Read More
27 October 2016 in Investor Center

Dr. Liam J. Hurley Joins Imagin Medical’s Scientific Board of Advisors

Vancouver, B.C. and Boston, MA, October 27, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that Dr. Liam J. Hurley, a…
Read More
20 October 2016 in Investor Center

Imagin Medical Closes Tranche 1 of Private Placement for $385,000

Vancouver, B.C. and Boston, MA, October 20, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that, further to its September 13,…
Read More
6 October 2016 in Investor Center

Imagin Medical’s Quality Management System Initial Phase Complete

Vancouver, B.C. and Boston, MA, October 6, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that the Company’s Quality Plan for…
Read More
29 September 2016 in Investor Center

Ken Daignault Joins Imagin Medical’s Board of Directors

Vancouver, B.C. and Boston, MA, September 29, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that Ken Daignault has joined Imagin’s…
Read More
22 September 2016 in Investor Center

Dr. Edward Messing, Chief of Urology, U Rochester Medical Center Joins Imagin Medical’s Scientific Board of Advisors

Vancouver, B.C. and Boston, MA, September 22 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that Dr. Edward Messing, Chair of Urology,…
Read More
15 September 2016 in Investor Center

Disruptive Technology Update

Vancouver, B.C. and Boston, MA, September 15, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) As a follow up to Imagin’s announcement of…
Read More
13 September 2016 in Investor Center

Imagin Medical Issues Private Placement

Vancouver, B.C. and Boston, MA, September 13, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today its intention to undertake a non-brokered…
Read More
1 August 2016 in Investor Center

American Urological Association’s New Guidelines for Bladder Cancer Support Imagin Medical’s Objective

Vancouver, B.C. and Boston, MA, August 1, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) is announcing that the recent publication of the…
Read More
20 July 2016 in Investor Center

Alpha Prototype on Schedule

Vancouver, B.C. and Boston, MA, July 20, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that the process of retrofitting and…
Read More
9 June 2016 in Investor Center

Imagin Signs Agreements to Support i/Blue Development: University of Rochester Laboratory of Laser Energetics and U.S. Department of Energy

Vancouver, B.C. and Boston, MA, June 9, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that it has signed a Collaborative…
Read More
24 May 2016 in Investor Center

Imagin Attended American Urological Association Annual Meeting

Vancouver, B.C. and Boston, MA, May 24, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”), as previously reported, attended the 2016 American…
Read More
10 May 2016 in Investor Center

Imagin Medical Now Trading on Frankfurt and Stuttgart Exchanges

Vancouver, B.C. and Boston, MA, May 10, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (the “Company”) is pleased to announce that its common shares now trade on the…
Read More
5 May 2016 in Investor Center

Imagin Medical Attends America Urology Association Annual Meeting

Vancouver, B.C. and Boston, MA, May 5, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (the “Company”) announced that President and CEO, Jim Hutchens, will be attending the 2016…
Read More
28 April 2016 in Investor Center

Imagin Medical Begins Trading on OTC

Vancouver, B.C. and Boston, MA, April 28, 2016 – Imagin Medical (CSE: IME) (OTC PINK:IMEXF) (the “Company”) announced that it has started trading on the OTC Pinksheets under the symbol…
Read More
24 April 2016 in Investor Center

Imagin Announces Dr. Ralph deVere White Named Chairman of the Scientific Advisory Board

Vancouver, B.C. and Boston, MA, April 26, 2016 – Imagin Medical (CSE: IME) (the “Company”) is pleased to announce that Ralph deVere White, M.D., has accepted the position of Chairman…
Read More
12 April 2016 in Investor Center

Imagin Announces i/Blue Product Development Program Moves to University of Rochester Laboratory for Laser Energetics (LLE)

Vancouver, B.C. and Boston, MA, April 12, 2016 – Imagin Medical (CSE: IME) (the “Company”) announced today that Dr. Stavros Demos, the inventor of the i/Blue Imaging System, has accepted…
Read More
9 March 2016 in Investor Center

Imagin Corporate Update – Prototype Development Launched with Boston Management Team

Vancouver, B.C., March 9, 2016 – Imagin Medical (CSE: IME) (the “Company”) is pleased to report it has begun development of its ultrasensitive i/Blue Imaging System. To be successful in…
Read More
23 February 2016 in Investor Center

Imagin Medical Starts Trading On the CSE

Vancouver, B.C., February 23, 2016 – Imagin Medical Inc. (formerly Expedition Mining Inc.) announces that further to its news release dated February 10, 2016, the Canadian Securities Exchange (“CSE”) has…
Read More
9 February 2016 in Investor Center

Acquisition Closing

Vancouver, B.C., February 10, 2016 – Expedition Mining Inc. (EXU) announces the closing of the private placement of $1,000,000 which completes the acquisition of BSS Life Sciences Inc., (herein to…
Read More
10 December 2015 in Investor Center

AGM results

Vancouver, B.C., December 10, 2015 –Expedition Mining Inc. (“EXU” or the “Company”) (CSE: EXU) is pleased to announce that at its Annual and Special Shareholders Meeting held on December 8,…
Read More
18 November 2015 in Investor Center

Update on Transaction with BSS

Vancouver, B.C., November 18, 2015 – Further to its press release of October 5, 2015, Expedition Mining Inc. (“EXU” or the “Company”) (CSE: EXU) provides an update on the status…
Read More
5 October 2015 in Investor Center

Definitive Agreement with BSS

Vancouver, B.C., October 5, 2015 – Further to its press release of July 9, 2015, Expedition Mining Inc. (“EXU” or the “Company”) (CSE: EXU) announces that it has signed a…
Read More
9 July 2015 in Investor Center

LOI with BSS

Vancouver, B.C., July 9, 2015 – Expedition Mining Inc. (the “Expedition” or the “Company”) (CSE:EXU) announces that it has signed a letter of intent with BSS Life Sciences Inc. (“BSS”)…
Read More